Aramark
ARMK · NYSE
About ARMK
- Employees
- 278,390
- Headquarters
- PHILADELPHIA, Pennsylvania
- Listed
- Dec 12, 2013
- Sector
- Consumer Discretionary
- Industry
- Hotels, Restaurants & Leisure
- Website
- aramark.com
ARMK key statistics
- Market cap
- 14.69B
- Price-earnings ratio
- 39.24
- Dividend yield
- 0.84%
- Average volume
- 2.32M
- Volume
- 1.87M
- Open price
- $55.77
- High today
- $56.25
- Low today
- $55.39
- 52 Week high
- $62.65
- 52 Week low
- $35.66
Aramark (ARMK) at a glance
Aramark (ARMK) last traded at $56.12, with a market cap of 14.69B, a price-to-earnings ratio of 39.24 and a dividend yield of 0.84%.
Today the stock has traded between $55.39 and $56.25. The current price is 1.3% above the day's low and 0.2% below its high.
Volume so far is 1.87M shares, in line with the average of 2.32M shares a day.
Over the past year Aramark has ranged from $35.66 to $62.65, and now sits 76% of the way up that range.
Aramark met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q3 FY26 it reported $0.52 per share against an estimate of $0.495.
The average analyst price target is $69.92, 24.6% above the current price, from 11 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy90.9%
- Hold9.1%
- Sell0.0%
- Low
- $49.70
- Now
- $56.12
- High
- $78.75
ARMK earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 3 of the last 8 quarters, by 3.7% on average.
- Q4 FY24: reported $0.54 per share against an estimate of $0.5442
- Q1 FY25: reported $0.51 per share against an estimate of $0.4896
- Q2 FY25: reported $0.34 per share against an estimate of $0.3335
- Q3 FY25: reported $0.40 per share against an estimate of $0.4072
- Q4 FY25: reported $0.57 per share against an estimate of $0.6662
- Q1 FY26: reported $0.51 per share against an estimate of $0.5132
- Q2 FY26: reported $0.48 per share against an estimate of $0.4831
- Q3 FY26: reported $0.52 per share against an estimate of $0.495
ARMK news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Aramark Sports + Entertainment Turns up the Heat for the 2026-27 Arena Season With Locally Inspired, Personalized Fan Experiences
- Press releaseBusiness Wire
Aramark Healthcare+ Named Top Overall Supplier on Modern Healthcare's "Best Places to Work™ in Healthcare" List
- Press releaseBusiness Wire
Aramark Nexus™ Selected as Premier Hospitality Partner for a Leading Workforce Housing Provider
- Press releaseBusiness Wire
Aramark Sports + Entertainment Kicks Off 2026 NFL Season Across Eight NFL Stadiums With New Menu Items, Enhanced Premium Experiences, and Local Partnerships
- Press releaseBusiness Wire
Aramark Collegiate Hospitality Builds Strong Momentum with Five New Partnerships
- Press releaseBusiness Wire
Aramark to Participate in Upcoming Goldman Sachs Conference
- Press releaseBusiness Wire
Aramark Collegiate Hospitality Introduces 2026-2027 Innovations for Current and Incoming Generations
Similar companies
Companies in the same industry as Aramark
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
- WFFWF Holding$0.0929−3.83%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.